Skip to main content

Misleading Claims Found on Websites Selling Anti-Mullerian Hormone Tests

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 22, 2023 -- Many misleading claims are made about the value of anti-Mullerian hormone (AMH) tests on websites that sell direct-to-consumer (DTC) AMH tests, according to a study published online Aug. 21 in JAMA Network Open.

Alexis Johnson, M.P.H., from the University of Sydney in Australia, and colleagues described and analyzed information on websites that sell DTC AMH tests in a qualitative study including content analysis of text information from websites in multiple countries that sell DTC AMH tests. The sample for analysis included 27 websites across seven different counties.

The researchers found considerable variation in information across websites, which was organized into six main categories: whether a test description was included (93 percent of websites); statements about what the test can do, including indicating ovarian reserve and likelihood of conceiving (96 and 74 percent, respectively); statements about usefulness of the test results, including adjustment of reproductive timeline and determining whether egg freezing was viable (41 and 30 percent, respectively); blood collection methods; promotion tactics, including stating the convenience of testing and using language promoting empowerment and control (89 and 26 percent); and statements about test limitations, including polycystic ovary syndrome falsely inflating AMH levels and inaccuracy in prediction of conception (48 and 33 percent).

"In this qualitative study including content analysis, websites across several countries offering DTC AMH testing were easily found through simple internet searches and most contained false and misleading claims about the utility of the AMH test," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals

TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study...

One in Nine U.S. Children Have Ever Been Diagnosed With ADHD

THURSDAY, May 23, 2024 -- Diagnoses of attention-deficit/hyperactivity disorder (ADHD) in U.S. children continue to increase, with approximately one in nine having ever received a...

ASCO: Survivors of Early Breast Cancer Can Successfully Attempt Pregnancy

THURSDAY, May 23, 2024 -- Most survivors of stage 0 to III breast cancer who attempt pregnancy postdiagnosis are able to become pregnant and have a live birth, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.